КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ Аденоматозный полипозный синдром
Аннотация
Разработчик клинических рекомендаций:
Ассоциация колопроктологов России,
Ассоциация медицинских генетиков
Кодирование по D12 Международной статистической
классификации болезней и проблем, связанных со здоровьем:
Возрастная группа: взрослые
Об авторе
Дмитрий Юрьевич ПикуновРоссия
Список литературы
1. Справочник по колопроктологии (под редакцией Ю.А.Шелыгина, Л.А. Благодарного). М.: Литтерра. 2012; 596 с./ Guide of coloproctology (edited by Yu.A.Shelygin, L.A. Grateful). M.: Litterra. 2012; 596 p. (in Russ.).
2. Цуканов А.С., Шелыгин Ю.А., Фролов С.А., Кузьминов А.М. Семейный аденоматоз толстой кишки. Хирург. 2017; 3: 14-24. / Tsukanov A.S., Shelygin Yu.A., Frolov S.A., Kuzminov A.M. Familial adenomatosis of the colon. Surgeon. 2017; 3:14-24. (in Russ.).
3. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 1991; 66: 589-600.
4. Herrera L, Kakati S, Gibas L, et al. Gardner syndrome in man with an interstitial deletion of 5q. Am J Med Genet. 1986; 25: 473-476.
5. Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell. 1991; 66: 601-613.
6. Nallamilli BRR, Hegde M. Detecting APC gene mutations in familial adenomatous polyposis (FAP). Curr Protoc Hum Genet. 2017; 92: 10.8.1-10.8.16. doi:10.1002/cphg.29
7. Fodde R. The APC gene in colorectal cancer. Eur J Cancer. 2002; 38(7): 867-871.
8. Tsukanov A.S., Pospekhova N.I., Shubin V.P., Kuzminov A.M., et al. Mutations in the APC gene in Russian patients with classic form of familial adenomatous polyposis. Russian Journal of Genetics. 2017; 53(3): 369375.
9. Kastrinos F, Syngal S. Inherited Colorectal Cancer Syndromes. Cancer J. 2011; 17(6): 405-415.
10. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C/T:A mutations in colorectal tumors. Nature Genetics. 2002; 30: 227-232.
11. Kantor M, Sobrado J, Patel S, et al. Hereditary Colorectal Tumors: A Literature Review on MUTYH-associated Polyposis. Gastroenterology Research and Practice. 2017; 2017:8693182. DOI: 10.1155/2017/8693182.
12. Nielsen M, Infante E, Brand R. MUTYH Polyposis. In: Adam M.P., Ardinger H.H., Pagon R.A. et al., editors. Gene Reviews® [Internet]. Seattle (WA): University of Washington, Seattle. 2012; 4 [Updated 2019 Oct].
13. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006; 101(2): 385-398.
14. Septer S, Lawson CE, Anant S, Attard T. Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate. Fam Cancer. 2016; 15(3): 477-485.
15. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность) (под редакцией А.Д. Каприна, В.В. Старинского, Г.В. Петровой). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2019; с. 11-12. / Malignant neoplasms in Russia in 2018 (morbidity and mortality) (edited by A.D. Kaprin, V.V. Starinsky, G.V. Petrova). Moscow: P.A. Herzen Institute of Medical Research - Branch of the Federal State Budgetary Institution "NMIC of Radiology" of the Ministry of Health of Russia. 2019; pp. 11-12. (In Russ.).
16. Цуканов А.С., Шубин В.П., Поспехова Н.И., Сачков И.Ю., Кашников В.Н., Шелыгин Ю.А. Наследственные раки желудочно-кишечного тракта. Практическая онкология. 2014; 15(3): 126-133. / Tsukanov A.S., Shubin V.P., Pospekhova N.I., Sachkov I.Yu., Kashnikov V.N., Shelygin Yu.A. Hereditary cancers of the gastrointestinal tract. Practical oncology. 2014; 15(3): 126-133. (In Russ.).
17. Rozen P, Macrae F. Familial adenomatous polyposis: The practical applications of clinical and molecular screening. Fam Cancer. 2006; 5: 227-235.
18. Цуканов А.С., Поспехова Н.И., Шубин В.П. и соавт.. Дифференциальный диагноз синдрома Линча от других форм неполипозногоколоректального рака среди российских пациентов. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014; 24(2): 78-84. / Tsukanov A.S., Pospekhova N.I., Shubin V.P., et al. Differential diagnosis of Lynch syndrome from other forms of non-polypous colorectal cancer among Russian patients. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014; 24(2): 78-84. (In Russ.).
19. Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA. 2012; 308: 485492.
20. Scheuner M, McNeel T, Freedman A. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med. 2010; 12: 726-735.
21. Цуканов А.С., Шубин В.П., Кузьминов А.М. и др. Дифференциальный диагноз MutYH-ассоциированного полипоза и спорадических полипов толстой кишки. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 28(6): 51-57. / Tsukanov A.S., Shubin V.P., Kuzminov A.M. et al. Differential diagnosis of MutYH-associated polyposis and sporadic colon polyps. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28(6): 51-57. (In Russ.). https://doi.org/10.22416/1382-4376-2018-28-6-51-57
22. Grover S., Kastrinos F., Steyerberg E.W. et al. Prevalence and Phenotypes of APC and MutYH Mutations in Patients with Multiple Colorectal Adenomas. JAMA. 2012; 308(5): 485-492.
23. Dinarvand P., Davaro E.P., Doan J.V. et al. Familial Adenomatous Polyposis Syndrome: An Update and Review of Extraintestinal Manifestations. Arch Pathol Lab Med. 2019; 143(11): 1382-1398.
24. Brensinger JD, Laken SJ, Luce MC, et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut. 1998; 43(4): 548-552.
25. Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet. 1998; 62: 1290-1301.
26. Lal G, Gallinger S. Familial adenomatous polyposis. Seminars in Surgical Oncology. 2000; 18: 314-323.
27. Novelli M. The pathology of hereditary polyposis syndromes. Histopathology. 2015; 66(1): 78-87.
28. Barrow P, Khan M, Lalloo F, Evans DG, et al. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg. 2013; 100:1719–1731.
29. Riley BD, Culver JO, Skrzynia C, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns. 2012; 21:151–161.
30. Brensinger JD, Laken SJ, Luce MC, et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut. 1998; 43(4): 548-552.
31. Talseth-Palmer BA. The genetic basis of colonic adenomatouspolyposis syndromes. Hereditary Cancer in Clinical Practice. 2017; 15:5. DOI 10.1186/s13053-017-0065-x
32. Jass JR. Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract. 2008;204(7):431-47.
33. Friedl W, Caspari R, Sengteller M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experiencefrom 680 FAP families. Gut. 2001;48:515-521.
34. Цуканов А.С. Стратегия комплексного молекулярно-генетического изучения наследственных форм колоректального рака у российских пациентов. Автореферат диссертации на соискание ученой степени доктора наук. М., 2017, 48 с. / Tsukanov A.S. Strategy of complex molecular genetic study of hereditary forms of colorectal cancer in Russian patients. Abstract of the dissertation for the degree of Doctor of Sciences. M., 2017, 48 p. (in Russ.).
35. Herzig D, Hardiman K, Weiser M, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes. Dis Colon Rectum. 2017; 60(9): 881-894.
36. Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015; 110(2): 223-263.
37. Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10-year prospective study. Gut. 2002; 50: 636-634.
38. Spigelman A, Talbot I, Williams C, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989; 334 (8666): 783-785.
39. Brosens LA, Keller JJ, Offerhaus GJA, et al. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut. 2005; 54 (7): 1034-1043.
40. Leone PJ, Mankaney G, Sarvapelli Sh, et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc. 2019;89(5):961-968.
41. Kallenberg FGJ, Bastiaansen BAJ, Dekker E, Cap-assisted forward-viewing endoscopy to visualize the ampulla of Vater and the duodenum in patients with familial adenomatous polyposis. Endoscopy. 2017;49(2):181-185.
42. de Marchis ML, Tonelli F, Quaresmini D, et al. Desmoid Tumors in Familial Adenomatous Polyposis. Anticancer Res. 2017; 37(7): 3357-3366.
43. Campos FG, Martinez CA, Novaes M, Nahas SC. Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis. Fam Cancer. 2015; 14(2): 211-219.
44. Будтуев А.С., Пикунов Д.Ю., Рыбаков Е.Г., Севостьянов С.И. Синдром низкой передней резекции прямой кишки и методы его хирургической коррекции. Вестник хирургии им. И.И. Грекова. 2014; 173(4): 106-110. / Budtuev A.S., Pikunov D.Yu., Rybakov E.G., Sevostyanov S.I. Low anterior rectal resection syndrome and methods of its surgical correction. Bulletin of Surgery named after I.I. Grekov. 2014; 173(4): 106-110. (in Russ.).
45. Подберзская А.А., Салмин Р.М., Могилевец Э.В. и соавт. Современные хирургические методы лечения полипоза толстой кишки. Журнал Гродненского государственного медицинского университета. 2016; 4(56): 26-29. / Podberezskaya A.A., Salmin R.M., Mogilevets E.V., et al. Modern surgical methods of treatment of colon polyposis. Journal of Grodno State Medical University. 2016; 4(56): 26-29. (in Russ.).
46. Фоменко О.Ю., Ачкасов С.И., Титов А.Ю. и соавт. Современные возможности улучшения функционального состояния запирательного аппарата у пациентов с наличием превентивных кишечных стом. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015; 25(5): 77-83. / Fomenko O.Yu., Achkasov S.I., Titov A.Yu. et al. Modern possibilities of improving the functional state of the locking device in patients with the presence of preventive intestinal stomas. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015; 25(5): 77-83. (in Russ.).
47. Roncucci L, Pedroni M, Mariani F. Attenuated adenomatous polyposis of the large bowel: Present and future. World J Gastroenterol. 2017; 23(23): 4135-4139.
48. Burns EM, Bottle A, Aylin P, et al. Volume analysis of outcome following restorative proctocolectomy. Br J Surg. 2011; 98: 408-417.
49. Sylla P, Chessin DB, Gorfine SR. et al. Evaluation of onestage laparoscopic-assisted restorative proctocolectomy at a specialty center: comparison with the open approach. Dis Colon Rectum. 2009; 52(3): 394-399.
50. Zhang H, Hu S, Zhang G, et al. Laparoscopic versus open proctocolectomy with ileal pouch-anal anastomosis. Minim Invasive Ther Allied Technol. 2007; 16(3): 187-191.
51. Norenberg D, Sommer WH, Thasler W, et al. Structured Reporting of Rectal Magnetic Resonance Imaging in Suspected Primary Rectal Cancer: Potential Benefits for Surgical Planning and Interdisciplinary Communication. Invest Radiol. 2017; 52(4): 232-239.
52. Ellis CN. Colonic adenomatous polyposis syndromes: clinical management. Clin Colon Rectal Surg. 2008; 21: 256-262.
53. Aziz O, Athanasiou T, Fazio VW, et al. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg. 2006; 93: 407-417.
54. Tajika M, Niwa Y, Bhatia V, et al. Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis. World J Gastroenterol. 2013; 19: 6774-6783.
55. Lynch РМ, Morris JS, Wen S, et al. Proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc. 2016; 84(1): 115125.
56. Knudsen A, Bisgaard M, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer. 2003; 2: 43-55.
57. Nascimbeni R, Pucciarelli S, Di Lorenzo D, et al. Rectum-sparing surgery may be appropriate for biallelic MutYH-associated polyposis. Dis Colon Rectum. 2010; 53:16701675.
58. Клинические рекомендации "Злокачественные новообразования ободочной кишки и ректосигмоидного отдела", год утверждения: 2020. http://cr.rosminzdrav.ru/recomend/396 1 / Clinical recommendations "Malignant neoplasms of the colon and rectosigmoid department", 2020. http://cr.rosminzdrav.ru/recomend/396 1 (in Russ.).
59. Клинические рекомендации "Рак прямой кишки", год утверждения: 2020. http://cr.rosminzdrav.ru/recomend/554_2. / Clinical recommendations "Rectal cancer", 2020. http://cr.rosminzdrav.ru/recomend/554_2. (in Russ.).
60. Nieuwenhuis MH, Lefevre JH, Bulow S, et al. Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum. 2011; 54: 1229-1234.
61. Speake D, Evans DG, Lalloo F, et al. Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg. 2007; 94: 1009-1013.
62. Quast DR, Schneider R, Burdzik E, et al. Long-term outcome of sporadic and FAP- associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Fam Cancer. 2016; 15: 31-40.
63. Клинические рекомендации "Кишечная стома у взрослых". 2017. http://akr-online.ru/press/clinical-guidelines/recommendationstoma.pdf. / Clinical recommendations "Intestinal stoma in adults". 2017. http://akr-online.ru/press/clinical-guidelines/recommendationstoma.pdf. (in Russ.).
64. Annibali R, Oresland T, Hulten L. Does the level of stapled ileoanal anastomosis influence physiologic and functional outcome? Dis Colon Rectum. 1994; 37: 321-329.
65. Фоменко О.Ю., Ачкасов С.И., Титов А.Ю. и соавт. Роль аноректальной манометрии, БОС-терапии и тибиальной нейромодуляции в диагностике и консервативном лечении анальной инконтиненции у пожилых. Клиническая геронтология. 2015; 5(6): 16-20. / Fomenko O.Yu., Achkasov S.I., Titov A.Yu. et al. The role of anorectal manometry, BOS therapy and tibial neuromodulation in the diagnosis and conservative treatment of anal incontinence in the elderly. Clinical gerontology. 2015; 5(6): 16-20. (in Russ.).
66. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991; 101: 635-639.
67. Steinbach G, Lynch PM, Phillips RKS, et al. The effect of celecoxib, a cyclooxygenase- 2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000; 342: 1946-1952.
68. Nugent KP, Farmer KC, Spigelman AD, et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg. 1993; 80: 1618-1619.
69. Higuchi T, Iwama T, Yoshinaga K, et al. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res. 2003; 9: 4756-4760.
70. Tonelli F, Valanzano R, Messerini L. et al. Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? J Surg Oncol. 2000; 74: 15-20.
71. Cruz-Correa M, Hylind LM, Romans KE, et al. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology. 2002; 122: 641-645.
72. International Society for Gastrointestinal Hereditary Tumours-InSiGHT. Fam Cancer. 2015; 14(Suppl 1): 1-91.
73. Bianchi LK, Burke CA, Bennett AE, et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008; 6: 180-185.
74. Walton S-J, Frayling IM, Clark SK, et al. Gastric tumours in FAP. Fam Cancer. 2017; 16: 363-369.
75. Vasen HF, Bulow S, Myrh0j T, et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut. 1997; 40: 716-719.
76. Bulow S, Christensen IJ, H0jen H, et al. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis. 2012; 14: 947952.
77. Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989; 2: 783-785.
78. Groves CJ, Saunders BP, Spigelman AD, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10-year prospective study. Gut. 2002; 50: 636641.
79. Shepherd NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol. 1987; 40: 601-607.
80. Setti Carraro PG, Talbot IC, Nicholls JR. Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study. Int J Colorectal Dis. 1998; 13: 103-107.
81. Friederich P, de Jong AE, Mathus-Vliegen LM, et al. Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008; 6: 1237-1642.
82. Speake D, Evans DG, Lalloo F, et al. Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg. 2007; 94: 1009-1013.
83. Ahmed Ali U, Keus F, Heikens JT, et al. Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis. Cochrane Database Syst Rev. 2009; (1) CD006267.
84. Ueno H, Kobayashi H, Konishi T, et al. Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol. 2016; 21(4): 713-722.
85. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995; 222: 120-127.
86. Vasen HF, van Duijvendijk P, Buskens E, et al. Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients. Gut. 2001;49(2):231-5.
87. NCCN Clinical Practice Guidelines in Oncology Genetic/Familial High-Risk Assessment: Colorectal version 1.2021.
88. Vasen HF, Möslein G, Alonso A, Aretz S, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57(5):704-13.
89. Aelvoet AS, Struik D, Bastiaansen BA J, et al. Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta‑analysis. Familial Cancer. (2022), https://doi.org/10.1007/s10689-022-00288-y
90. Jannasch O, Evert M, Rapp L, Lippert H, Meyer F. Aktuelle Diagnostik und Therapie von Desmoidtumorenbei Patienten mit familiärer adenomatöser Polyposis - auschirurgischer Sicht [Current diagnosis and treatment of desmoid tumours in patients with familial adenomatous polyposis - the surgical view]. Zentralbl Chir. German. 2010;135(1):34-43. DOI: 10.1055/s-0028-1098794.
Рецензия
Для цитирования:
Пикунов Д.Ю. КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ Аденоматозный полипозный синдром. Колопроктология. 2022;21(2).
For citation:
Pikunov D.Yu. CLINICAL RECOMMENDATIONS Adenomatous polyposis syndrome. Koloproktologia. 2022;21(2).
Послать статью по эл. почте 
